Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2695521000168110 | Mycoderm (butyl hydroxybenzoate 10 mg / 1 g + salicylic acid 40 mg / 1 g + sodium propionate 2 mg / 1 g) powder, 75 g (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2695531000168113 | Mycoderm powder, 75 g | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Mycoderm powder, 75 g | Is a | trade product pack | true | Inferred relationship | Some | ||
Mycoderm powder, 75 g | Is a | salicylic acid 4% + butyl hydroxybenzoate 1% + sodium propionate 0.2% powder, 75 g | true | Inferred relationship | Some | ||
Mycoderm powder, 75 g | has TPUU | Mycoderm powder | true | Inferred relationship | Some | 1 | |
Mycoderm powder, 75 g | has TP | Mycoderm | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Mycoderm powder, 75 g, bottle | Is a | True | Mycoderm powder, 75 g | Inferred relationship | Some |
Reference Sets
Trade product pack reference set